コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n information campaign might be an effective countermeasure.
2 V-1 overcame this obstacle by using Vpu as a countermeasure.
3 uture development of a pan-filovirus medical countermeasure.
4 ht therapy and the use of light as a fatigue countermeasure.
5 bility to investigate this virus and develop countermeasures.
6 kers can design and implement more effective countermeasures.
7 of L- and S-tetherins to primate lentiviral countermeasures.
8 of RVF and to use for evaluation of medical countermeasures.
9 remarkable diversity of immune responses and countermeasures.
10 microbial resistance (AMR) demands immediate countermeasures.
11 r ability to study Ebola viruses and develop countermeasures.
12 o better model disease and develop antiviral countermeasures.
13 s animal model for testing candidate medical countermeasures.
14 anding pathogenesis and developing effective countermeasures.
15 ceivers to confound the deception test using countermeasures.
16 ) mice an excellent choice to assess medical countermeasures.
17 eployment of novel and potent anti-infective countermeasures.
18 pathways against which viruses have evolved countermeasures.
19 ion genetics of a drive and proposed genetic countermeasures.
20 nt, production and distribution of effective countermeasures.
21 the pathogenesis of melioidosis and medical countermeasures.
22 immune response to serve as potential viral countermeasures.
23 tion sustains an ongoing quest for effective countermeasures.
24 ther investigation of viral pathogenesis and countermeasures.
25 o increased interest in developing effective countermeasures.
26 sis models for the rapid testing of possible countermeasures.
27 s, highlight the need for effective poxvirus countermeasures.
28 reagents, vaccines, therapeutics, and other countermeasures.
29 ied, precluding the development of effective countermeasures.
30 virions and for developing related antiviral countermeasures.
31 agents could potentially be used as medical countermeasures.
32 ent; and to assess the effectiveness of such countermeasures.
33 free space communications, and illuminators/countermeasures.
34 eed for research aimed at developing medical countermeasures.
35 DA approved pharmaceutical agents or medical countermeasures.
36 logy is desperately needed to develop better countermeasures.
37 of or after treatment with candidate medical countermeasures.
38 Efficacy of drive reversal varies between countermeasures.
39 ers cooperation in the absence of additional countermeasures.
40 virus, underscoring the need for efficacious countermeasures.
41 yelitis for the development of novel medical countermeasures.
42 elopment of effective therapeutics and viral countermeasures.
43 pathology and as a possible target for novel countermeasures.
44 virus transmission is critical to developing countermeasures.
45 tion are needed as early screens for medical countermeasures.
46 for various applications including infrared countermeasures.
47 the ensuing damage by responding with immune countermeasures.
48 dity, and ethics of clinical studies of such countermeasures?
50 ng the potential development of BCX4430 as a countermeasure against human filovirus diseases and othe
52 k during non-epidemic periods or as an early countermeasure against nascent outbreaks could therefore
54 tion of nano-OPH as a catalytic bioscavenger countermeasure against organophosphorus chemical warfare
55 anti-ceramide therapeutics and an effective countermeasure against radiation GI syndrome mortality.
56 e tested the effect of different lights as a countermeasure against sleep-loss decrements in alertnes
57 te that targeting this pathway may provide a countermeasure against the damaging effects of IR exposu
59 d the released OPAA may be used as a medical countermeasure against the organophosphorus nerve agents
60 t of lipid-nanoparticle-delivered siRNA as a countermeasure against this highly lethal human disease.
62 nly used to evaluate the efficacy of medical countermeasures against anthrax in support of licensure
69 r structure should inform rational design of countermeasures against HCMV, other herpesviruses, and e
71 ivo conditions indicated that many bacterial countermeasures against host defenses remain critical fo
76 , ciprofloxacin is part of the first-line of countermeasures against numerous high consequence bacter
77 used as a platform for delivering biological countermeasures against pandemic and biological threats.
78 The rapid development of effective medical countermeasures against potential biological threat agen
86 d is therefore one of the primary targets of countermeasures against these dangerous infectious agent
87 likely to be appropriate for testing medical countermeasures against this EBOV-Makona stock but may p
94 accelerate the development of effective ZIKV countermeasures and increase our preparedness against th
95 such as Pseudomonas syringae, have developed countermeasures and inject virulence proteins into the h
96 point to the need for evaluating therapeutic countermeasures and studying the pathophysiologic effect
98 that BatA is a target for developing medical countermeasures and that vaccination with a mutant lacki
101 to mechanisms of host innate immunity, viral countermeasures, and the evolutionary interplay between
102 ir high mortality rates, the lack of medical countermeasures, and their potential use as instruments
106 thogenicity and the development of effective countermeasures are restricted by the current biosafety
107 y in self-correction: Whereas the claim that countermeasures are sufficient is always subject to corr
110 zole aldoximes allows the design of a new OP countermeasure by conversion of hBChE from a stoichiomet
112 l strategy for "non-antibody-based" pathogen countermeasure by targeting the very same "alternative m
117 race between prey and predator, measures and countermeasures continuously evolve to increase survival
118 This balance of host response and pathogen countermeasures contributes to chronic infection in high
119 severe hemorrhagic fevers in humans, with no countermeasures currently being available, and must be s
121 to evaluate the efficacy of several specific countermeasures developed through years of preclinical w
122 avirus infection and provide new avenues for countermeasure development against pathogenic bunyavirus
123 ging of infectious disease processes may aid countermeasure development and lead to an improved under
125 esponses and protective effects of radiation countermeasure drugs, whereas conventional bone marrow c
126 The development and testing of new medical countermeasures, e.g., vaccines, are thus priorities; ho
128 An obvious conclusion is that the exercise countermeasures employed were incapable of providing the
131 dy treatment is currently the only available countermeasure for botulism, a fatal illness caused by f
132 xmedetomidine constitutes a highly effective countermeasure for cocaine's sympathomimetic actions on
135 ral drugs is also an important public health countermeasure for preventing and treating influenza, th
136 , Uber has been characterized as a potential countermeasure for reducing the estimated 121 million ep
138 used prophylactically or therapeutically as countermeasures for a variety of infectious diseases.
142 g the pathogenesis of and evaluating medical countermeasures for persisting Middle East respiratory s
143 dvance the understanding of the use of these countermeasures for post-exposure prophylaxis against Eb
144 elopment and selection of the most effective countermeasures for prophylactic as well as therapeutic
148 st defense and allow us to propose that as a countermeasure, geminivirus proteins reverse TGS by nons
149 gnized, and the need for developing suitable countermeasures has become especially acute following th
154 r speculated attack capabilities can argue a countermeasure in, but no possible observation argues on
156 must suppress or evade an array of host cell countermeasures in order to establish a productive infec
157 virulence factors and targets for developing countermeasures in pathogenic Gram-negative bacteria.
158 celerate the development of specific medical countermeasures in preparation for a future disease outb
160 developing and testing, in clinical trials, countermeasures in the form of antiviral drugs and vacci
161 and for implementation of effective medical countermeasures, in case a "biological cloud" is seen ov
166 y have unanticipated activities as potential countermeasures is one way to meet this important goal,
168 he unusual, anionic dermcidin with effective countermeasures likely contributes to the extraordinary
171 demonstrate that promising candidate medical countermeasures may not completely clear EBOV infection.
172 are sometimes harmful to females, and female countermeasures may thwart the interests of males, which
177 into the role of cellular miRNAs in possible countermeasures of HCV for suppression of the host antiv
182 a broad antiviral strategy to antagonize the countermeasures of viruses and bypass the dsRNA-induced
184 Whether host autophagic responses and viral countermeasures play similar roles in plant-virus intera
187 overy posts a challenge to develop effective countermeasures, provides a novel tool for studying intr
190 at began in late 2013, the lack of effective countermeasures resulted in chains of serial infection a
192 decoding validity may be the deployment of "countermeasures": strategies used to mask memory signals
194 e addressed by efficient, quickly deployable countermeasures such as antidotes reactivating acetylcho
196 Here we show that unlike other virus-encoded countermeasures, such as those from primate viruses rela
197 h on injury control; to design and implement countermeasures that address injury risk factors and def
201 employ to prevent rotavirus invasion and the countermeasures that these viruses have successfully dev
203 fection are useful for screening prospective countermeasures, they are frequently not useful for pred
205 in recent years as a potential prophylactic countermeasure to decrease the prevalence of hospital-ac
206 by a parasite and represents a new potential countermeasure to evade the generation of a correct immu
207 the final stage of pursuit, presumably as a countermeasure to keep evading moths within their "acous
208 e that the ICP0-PML.I interaction reflects a countermeasure to PML-related antiviral restriction.
209 infected cells has been proposed as a viral countermeasure to potential host cell RNA interference-b
210 other industries, but the use of a nap as a countermeasure to prevent fatigue in residents is uncert
211 equate protein is consumed at each meal as a countermeasure to sarcopenia are presented and discussed
216 based design and optimization of therapeutic countermeasures to combat this potential agent of bioter
217 mmune responses, viruses have also developed countermeasures to defeat dsRNA-induced antiviral strate
219 ggest that GraS mediates specific resistance countermeasures to HDPs in immune contexts that are high
226 ve care unit-associated weakness and develop countermeasures to preserve muscle function, lessen illn
227 Based on the proposed reaction mechanisms, countermeasures to prevent Cr oxidation (addition of NH4
228 us to pinpoint a possible source and to take countermeasures to prevent further spread of the epidemi
229 ecovery in space flight, as well as possible countermeasures to prevent immunosuppression or enhance
230 tion and for the initial phase of developing countermeasures to prevent or treat viral infections.
232 tes has increased efforts to develop medical countermeasures to protect against radiation toxicities
235 hosts have developed a variety of metabolic countermeasures to sense and resist these viral changes.
236 t, underscoring the importance of developing countermeasures to SIV that are effective before infecti
240 being essential for controlling host defense countermeasures triggered by microbial cytosolic DNA and
241 be used in a potential bioterrorist attack, countermeasures urgently are needed to counteract the pa
243 nerability of fMRI-based memory detection to countermeasures, using a paradigm that bears resemblance
244 continued investments in the development of countermeasures (vaccines, therapeutic agents, and diagn
245 Without the transmembrane potential as a countermeasure, water will readily flow inside the highe
247 ens and for initiating cellular host defence countermeasures, which include the production of type I
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。